Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention

Steven R. Steinhubl, Kandice Kottke-Marchant, David J. Moliterno, Monique L. Rosenthal, Nikki K. Godfrey, Barry S. Coller, Eric J. Topol, A. Michael Lincoff

Research output: Contribution to journalArticlepeer-review

106 Scopus citations

Fingerprint

Dive into the research topics of 'Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science